Human-Relevant Neural Context

Why Test Toxicity Across Neurons and Glia?

Neural injury is not exclusively neuronal. Astrocytes regulate extracellular ions and neurotransmitters, provide metabolic support, influence synaptic maturation, and change state in response to stress or inflammation. A compound can therefore alter neuronal activity without immediately reducing cell number, or it can trigger glial responses that amplify, buffer, or reveal delayed toxicity.

Human co-cultures provide a controlled way to examine these interactions while preserving cell-type-resolved interpretation. Depending on the research question, the study can emphasize acute functional perturbation, repeated or prolonged exposure, recovery after washout, concentration-response relationships, or comparison of candidate molecules and controls.

Neurotoxicity Study Capabilities

A modular study design connects the biological model, exposure paradigm, and readouts to the decision the data must support.

Co-culture and Exposure Design

  • Human neuronal and glial cell combinations selected for the study objective
  • Acute, repeated-dose, prolonged-exposure, recovery, and concentration-response formats
  • Vehicle, baseline, positive-control, and comparator conditions
  • Optional inflammatory or oxidative challenge contexts when scientifically justified

Integrated Experimental Support

  • Pilot optimization before a larger compound set or deeper characterization
  • Parallel functional, morphological, viability, and mechanism-oriented endpoints
  • Plate-level quality review, quantitative analysis, visualization, and interpretation
  • Study extensions informed by the first dataset rather than a fixed assay package
Configure a Co-culture Study

Study Design Options

A fit-for-purpose design begins with the biological question rather than a fixed panel. The configurations below show how model context, exposure pattern, and endpoint selection may be combined; final feasibility and assay composition are confirmed during project planning.

Research Focus Possible Configuration Informative Readouts Decision Supported
Early liability ranking Baseline human neuron-glia co-culture with a concentration series Cell health, neurite morphology, and a selected functional endpoint Prioritize compounds for deeper investigation
Functional neurotoxicity Network-mature co-culture with acute and delayed observation points MEA or calcium dynamics paired with viability Separate activity changes from overt cell loss
Glia-associated susceptibility Baseline and challenge-context comparison when scientifically justified Cell-type markers, stress signals, function, and survival Assess context-dependent vulnerability or protection
Recovery potential Exposure followed by washout and post-treatment monitoring Repeated functional measurements and terminal morphology Distinguish transient disruption from persistent injury

Acute Perturbation

Short exposure windows can emphasize rapid changes in excitability, signaling, or membrane integrity.

Repeated Exposure

Multiple treatments can address cumulative or delayed effects that a single time point may miss.

Challenge Context

A defined inflammatory or oxidative context may test whether toxicity changes under neural stress.

Washout & Recovery

Post-exposure monitoring can reveal reversibility, adaptation, or continued deterioration.

Multiparametric Neurotoxicity Endpoints

Neural Network Function

MEA-based activity measurements can capture firing, bursting, synchrony, and network-level changes. Related options include MEA measurements of neurons and broader neuronal activity monitoring.

Calcium Dynamics

Kinetic calcium signals can reveal altered excitability and coordinated activity before overt cell loss. A dedicated calcium assay service can be integrated when it fits the biological question.

Cell Health and Morphology

Viability, membrane integrity, apoptosis-related markers, neurite architecture, cell counts, and mitochondrial or oxidative-stress signals can be combined to distinguish functional perturbation from generalized cytotoxicity.

Cell-Type and Mechanistic Readouts

Immunostaining and molecular measurements can track neuronal and glial identity, stress responses, synaptic features, and selected pathway changes. High-content screening is useful when spatial and cell-resolved phenotypes are central.

Integrated Interpretation

From Individual Readouts to a Toxicity Profile

No single endpoint captures every form of neural injury. A stronger interpretation compares when each signal changes, at what concentration, in which cell population, and whether the phenotype resolves after exposure ends.

1. Functional perturbation
Does network activity, synchrony, or calcium behavior change before a detectable decline in cell health?
2. Structural and cellular injury
Are neurites, nuclei, membranes, mitochondria, or survival markers altered in a concentration- or time-dependent pattern?
3. Neuron-glia relationship
Do cell-type-resolved measures suggest a direct neuronal effect, a glial response, or an interaction between the two?
4. Persistence and recovery
Does the phenotype normalize after washout, remain stable, or progress after the test article is removed?
Controls matter: Vehicle controls, assay-appropriate reference conditions, baseline qualification, and replicate structure are planned around the endpoint set so that biological effects can be interpreted against technical variability.

Study Workflow

  1. 1

    Define the decision and risk context

    Align the compound class, expected exposure, intended comparison, key liabilities, and success criteria.

  2. 2

    Design the co-culture and assay matrix

    Select cell composition, culture format, dosing schedule, controls, time points, replicates, and complementary endpoints.

  3. 3

    Qualify the experimental system

    Review baseline cell identity, morphology, health, and functional behavior before test-article interpretation.

  4. 4

    Execute exposure and acquire data

    Run the agreed treatment design with plate controls and endpoint-specific acquisition procedures.

  5. 5

    Analyze, interpret, and plan next steps

    Integrate concentration- and time-dependent effects across readouts, document limitations, and identify confirmation or mechanism studies.

Applications

CNS Candidate De-risking

Compare related molecules, formulations, or exposure conditions for liabilities affecting neural health or activity.

Drug-Induced Functional Liability

Investigate hyperactivity, suppression, disrupted bursting, or altered synchrony alongside cell-health measures.

Environmental and Chemical Toxicology

Profile compounds or mixtures using human-relevant cellular and functional endpoints across concentration and time.

Inflammation and Glia-Mediated Injury

Examine how inflammatory stimuli or glial state influence neuronal function, survival, and recovery.

Mechanistic Follow-up

Connect an initial phenotype to oxidative stress, mitochondrial dysfunction, apoptosis, neurite injury, or selected signaling changes.

Model and Assay Qualification

Assess whether a co-culture format and endpoint combination is fit for a planned screening or translational research program.

Programs requiring adjacent expertise can also draw on Neurost's neurotoxicity screening service, basic neuroscience assays, and available iPSC-derived neural models.

Study Advantages and Deliverables

Advantages

  • Human neural biology with explicit neuron-glia interaction
  • Functional and structural endpoints interpreted together
  • Flexible exposure designs for acute and delayed effects
  • Scalable pilot-to-follow-up collaboration
  • Study design anchored to the intended research decision

Typical Deliverables

  • Agreed study plan and experimental condition matrix
  • Quality-control and assay-performance summary
  • Processed datasets with endpoint definitions
  • Figures and concentration- or time-response summaries
  • Interpretive report describing results, limitations, and recommended next steps
Request a Tailored Proposal

Related Research

A dynamic neuron-astrocyte model for organophosphate injury

Liu and colleagues used a 3D brain-on-chip containing human iPSC-derived GABAergic neurons and astrocytes to study malathion exposure and post-exposure intervention. Its direct relevance lies in pairing a defined toxicant challenge with co-culture architecture, viability assessment, and mechanism-related measurements.

Liu, Lumei, et al. “Three-Dimensional Brain-on-Chip Model Using Human iPSC-Derived GABAergic Neurons and Astrocytes: Butyrylcholinesterase Post-Treatment for Acute Malathion Exposure.” PLOS ONE, vol. 15, no. 3, 2020, e0230335. https://doi.org/10.1371/journal.pone.0230335

MEA detection of inflammation-associated functional change

Goshi and colleagues examined prolonged TNF-alpha and IL-6 exposure in human iPSC-derived neuron/primary astrocyte co-cultures using MEA features alongside viability, secreted cytokines, and gene expression. The study demonstrates the value of time-resolved network activity for detecting exposure effects and interpreting them beside cellular and molecular outcomes.

Goshi, Noah, et al. “Direct Effects of Prolonged TNF-α and IL-6 Exposure on Neural Activity in Human iPSC-Derived Neuron-Astrocyte Co-Cultures.” Frontiers in Cellular Neuroscience, vol. 19, 2025, article 1512591. https://doi.org/10.3389/fncel.2025.1512591

Translate the Evidence into a Study

Frequently Asked Questions

Request a Quote

Fill out the form below, and our expert team will contact you to design your custom project and accelerate breakthrough innovations.

For Research Use Only. Not For Clinical Use.

Inquiry Basket